Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results
Provided By PR Newswire
Last update: Mar 21, 2025
Strategic Acquisition of Intellectual Property of BRII-179, a Wholly Owned Phase 2b Asset Capable of Combining with Multiple HBV Treatment Modalities for Cure
Read more at prnewswire.com
